
Sign up to save your podcasts
Or


In this episode, we review the three oral P2Y12 inhibitors on the market (clopidogrel, prasugrel, ticagrelor) and discuss each agent's clinical pearls, comparative effectiveness, and unique precautions.
By Sean P. Kane, PharmD; Khyati Patel, PharmD4.9
646646 ratings
In this episode, we review the three oral P2Y12 inhibitors on the market (clopidogrel, prasugrel, ticagrelor) and discuss each agent's clinical pearls, comparative effectiveness, and unique precautions.

43,334 Listeners

700 Listeners

499 Listeners

263 Listeners

3,337 Listeners

56,388 Listeners

1,156 Listeners

16,958 Listeners

401 Listeners

731 Listeners

303 Listeners

196 Listeners

515 Listeners

107 Listeners

156 Listeners